Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 42, 2008, Pages 16278-16283

  Weber, Christian ^a   Kraemer, Sandra ^a   Drechsler, Maik ^a   Lue, Hongqi ^a   Koenen, Rory R ^a   Kapurniotu, Aphrodite ^b   Zernecke, Alma ^a   Bernhagen, Jürgen ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Chemokine; CXC chemokine; Cytokine; ELR+

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; GLUTAMYLLEUCYLARGININE; MACROPHAGE MIGRATION INHIBITION FACTOR; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CAROTID ARTERY; CELL CYCLE ARREST; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MONOCYTE; MOUSE; MUTATION; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; STRUCTURE ANALYSIS;

ANIMALS; ATHEROSCLEROSIS; CELL MOVEMENT; CELLS, CULTURED; HUMANS; INFLAMMATION; LEUKOCYTES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, KNOCKOUT; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-8B;

EID: 55849139457     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0804017105     Document Type: Article

References (34)

1. Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891-928.
2. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610-621.
3. Weber C, Schober A, Zernecke A (2004) Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 24:1997-2008.
4. Alcami A (2003) Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3:36-50.
5. Murphy PM (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2:116-122.
6. Aliberti J, et al. (2003) Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 4:485-490.
7. Hoover DM, et al. (2002) The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 277:37647-37654.
8. Yang D, et al. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528.
9. Howard OM, et al. (2005) Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate. Blood 105:4207-4214.
10. Howard OM, et al. (2002) Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 196:781-791.
11. Wakasugi K, Schimmel P (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284:147-151.
12. Calandra T, Roger T (2003) Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 3:791-800.
13. Morand EF, Leech M, Bernhagen J (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5:399-410.
14. Zernecke A, Bernhagen J, Weber C (2008) Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117:1594-1602.
15. Bernhagen J, et al. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587-596.
16. Dewor M, et al. (2007) Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in scratch-wounded monolayers in vitro. FEBS Lett 581:4734-4742.
17. Schober A, Bernhagen J, Weber C (2008) Chemokine-like functions of MIF in atherosclerosis. J Mol Med 86:761-770.
18. Hebert CA, Vitangcol RV, Baker JB (1991) Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 266:18989-18994.
19. Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M (1993) Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 90:3574-3577.
20. Jones SA, Dewald B, Clark-Lewis I, Baggiolini M (1997) Chemokine antagonists that discriminate between interleukin-8 receptors: selective blockers of CXCR2. J Biol Chem 272:16166-16169.
21. Prado GN, et al. (2007) Chemokine signaling specificity: essential role for the N-terminal domain of chemokine receptors. Biochemistry 46:8961-8968.
22. Rajagopalan L, Rajarathnam K (2006) Structural basis of chemokine receptor function-a model for binding affinity and ligand selectivity. Biosci Rep 26:325-339.
23. Sun H, Bernhagen J, Bucala R, Lolis E (1996) Crystal structure at 2.6 Å resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 93:5191-5196.
24. Kleemann R, et al. (2000) Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor: full immunologic activity of N-terminally truncated mutants. Eur J Biochem 267:7183-7193.
25. Murphy PM, et al. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176.
26. Oppenheim JJ, Yang D (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17:359-365.
27. Boisvert WA, et al. (2006) Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 168:1385-1395.
28. Pan JH, et al. (2004) Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109:3149-3153.
29. Weber C, Aepfelbacher M, Haag H, Ziegler-Heitbrock HW, Weber PC (1993) Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells. Eur J Immunol 23:852-859.
30. Bernhagen J, et al. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration Inhibitory factor (MIF). Biochemistry 33:14144-14155.
31. Bernhagen J, et al. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759.
32. Nguyen MT, et al. (2003)Asixteen residue peptide fragment of macrophage migration inhibitory factor, MIF(50-65), exhibits redox activity and has MIF-like biological functions. J Biol Chem 278:33654-33671.
33. Fingerle-Rowson G, et al. (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100:9354-9359.
34. Huo Y, et al. (2001) The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 108:1307-1314.